ImmuneOnco Biopharmaceuticals’ HK$234 Million Shares Placement

Leila Ahmed Asia & Pacific Legal Chronicle
Tagged:

Kirkland & Ellis represented the sole overall coordinator and placing agent, China International Capital Corporation Hong Kong Securities Limited, in the transaction.ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (“ImmuneOnco…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here